IPO fees to increase from 1 April 2026 We wrote to you in November announcing a fee increase across all IP rights, due to come into effect on 1 April 2026, subject to parliamentary approval. Fees will be increasing by an average of 25%. For example, a patent search is going up from £150 to £200 and a trade mark…
Ben KempJanuary 23, 2026
Enhancing collaboration for health security Enhanced cooperation was at the forefront of the Health Security Committee (HSC) plenary in Brussels on 14-16 January 2026, with discussions focussed on enhancing health security preparedness and protecting citizens. The meeting took place back-to-back with a meeting of the G7 Global Health Security Initiative, highlighting the benefits of global collaboration in the face of…
Ben KempJanuary 23, 2026
Dear members, please let me know via regulatory@bivda.org.uk any feedback to the TGA Australia - Proposed amendments relating to transparency of disruptions to supply of medical devices. Consultation closes 20th Feb 2026. TGA want your feedback on the proposed changes to improve transparency about disruptions to the supply of medical devices. Consultation: Improved sharing of information about medical…
Ben KempJanuary 15, 2026
Please see below update from the International Serum Industry Association, regarding intensified official controls and imposed checks at EU borders impacting Animal By-products INTERNATIONAL SERUM INDUSTRY ASSOCIATIONINTERNATIONAL SERUM INDUSTRY ASSOCIATION1,309 followers1,309 followers Reminder: Intensified Official Controls and Imposed Checks On 9 December the European Commission announced a reinforcement of controls on food, animal and plant products entering the EU. The…
Ben KempJanuary 12, 2026
Dear Members, please be advised that TGA Australia are running a consultation on the Conformity Assessment Procedures for medical devices – proposed amendments. The consultation closes 27th Feb 2026. Please provide any feedback to regulatory@bivda.org.uk This is particularly relevant as TGA Australia is a proposed jurisdiction that will be recognised by the MHRA for international reliance, under the proposed changes…
Ben KempJanuary 12, 2026
Dear Members, IMDRF issued its 2026-2030 strategic plan. The strategic plan outlines the mission, objectives, and priorities of the International Medical Device Regulators Forum (IMDRF). This directly and indirectly impacts BIVDA members, one by setting the guidance that a number of key regulators base their legislative principles on, and also increasingly by setting the minimum requirements that allow international reliance…
Ben KempJanuary 12, 2026
Dear Members, NMPA - China have updated their Medical Device GMP requirements, and this will apply from 1st November 2026 Revision and Release of the Good Manufacturing Practice for Medical Devices
Ben KempJanuary 12, 2026